Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions.
about
Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-IStructural Insights into High Density Lipoprotein: Old Models and New FactsDouble Superhelix Model of High Density LipoproteinThe cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effectsIsolation, characterization, and stability of discretely-sized nanolipoprotein particles assembled with apolipophorin-IIIHaptoglobin increases with age in rat hippocampus and modulates Apolipoprotein E mediated cholesterol trafficking in neuroblastoma cell lines.MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteinsStructure and stability of apolipoprotein a-I in solution and in discoidal high-density lipoprotein probed by double charge ablation and deletion mutationNanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung.In vivo administration of BL-3050: highly stable engineered PON1-HDL complexesCongruency between biophysical data from multiple platforms and molecular dynamics simulation of the double-super helix model of nascent high-density lipoprotein.Interaction of phospholipid transfer protein with human tear fluid mucins.Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.Immunochemical Approach for Monitoring of Structural Transition of ApoA-I upon HDL Formation Using Novel Monoclonal AntibodiesImaging and manipulation of high-density lipoproteins.Predicting the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks.The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses.Elliptical structure of phospholipid bilayer nanodiscs encapsulated by scaffold proteins: casting the roles of the lipids and the proteinConjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitisStimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation.Interaction of alpha-tocopherol with model human high-density lipoproteins.The terminal complement proteins C5b-9 augment binding of high density lipoprotein and its apolipoproteins A-I and A-II to human endothelial cellsHDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells.Nanodiscs as a new tool to examine lipid-protein interactions.Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux.Domains of apoE4 required for the biogenesis of apoE-containing HDL.High-density lipoprotein attenuates Th1 and th17 autoimmune responses by modulating dendritic cell maturation and function.Different Functional and Structural Characteristics between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic ActivityExpression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolismA monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G proteinProtein carbamylation renders high-density lipoprotein dysfunctional.Apolipoprotein A-I helical structure and stability in discoidal high-density lipoprotein (HDL) particles by hydrogen exchange and mass spectrometry.Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic ProcessDirect detection of ABCA1-dependent HDL formation based on lipidation-induced hydrophobicity change in apoA-IPreparation and activity analysis of recombinant human high-density lipoproteinLipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPSOptimized negative-staining electron microscopy for lipoprotein studies.New Insights into the High-Density Lipoprotein DilemmaIdentification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction
P2860
Q24629008-2EA9913D-2D2A-42E9-A260-E6D301805199Q26770434-E7490749-79AD-47A9-B0C4-41EA1BDF7B41Q27657720-50B32FA0-01D9-4363-A335-0253AC40ADF2Q28388695-9DBBD96E-6654-4691-9A75-CA60061A1A15Q28474859-18B0CE9D-426E-4574-8722-21914E6161BBQ29346953-04C63614-F6CA-4605-B880-85CD1CD213D2Q29615034-958B2755-F35A-41DB-AC67-B2A50E05D283Q30352647-9220ED8B-D58C-4CA0-AAB0-7C1527E2DBFBQ30431169-F7D66502-D3F1-46A1-9B85-AC193E7349B0Q30891417-FEB9D965-9F15-4C35-93A0-D7066D590EA4Q33650108-23DD54EE-24A3-469C-BE1C-8F9305006BE3Q33666024-52FF1598-0006-4824-985D-EDE5F476488EQ33675617-ACD749C4-C7CB-4A73-BA29-994732F280DDQ33687423-1E2C655D-5A46-4574-92A8-89BC2B4C450DQ33774419-E9D685E6-8A09-419D-842E-73B675CF1B27Q33907319-9EDB86AA-2CF8-44F7-ADFD-E19B21B936C3Q33907732-3BFCBA63-CA07-4C00-8CCF-1247897A62E4Q33987937-554A2C82-8348-4A67-8B8E-44F99EB604A6Q33997831-E75323DA-49F6-48BE-B84E-CB1147B13C6FQ34053031-6E06E401-ADC4-40E2-BA50-5B82B30920BDQ34119238-23FFCC04-2FF7-42EC-9FAE-C6CE50A907E6Q34169578-26B2C5AA-F247-478D-868F-A3819AB23D34Q34213160-1C8584C8-8EAA-492D-A2AD-8E42F92C3168Q34307544-7D503E67-1CEF-4389-B040-2D3FF7F72103Q34359526-4874E4CF-7D01-4857-9A8E-FF9A8DC2E74EQ34797618-902A8BA7-B779-4653-A05B-8B48AFE0642CQ35031146-E5153AC8-CF72-41CD-95C3-4C9009993A9AQ35562936-B3DB804D-0040-47CE-9D81-25A1F12CE706Q35749744-81174A57-2567-4C4B-A20C-E27E03DE9216Q35763106-729DB6AA-E866-4826-A6C1-A173740805BEQ35778121-F61D4F73-34EE-4CA8-B5DE-09AC2CD7A86BQ36050583-6752CBB7-A918-4BF4-BA0B-3599EC468184Q36122958-698D5258-8785-4BA3-9D51-4AA88DA79FB8Q36162860-3D5FDB04-DCAD-4F79-A8B2-A5322BA187FEQ36196870-6B6B48E5-3E00-4940-B1A5-B74E572C7CD7Q36297930-B2878825-50C5-4C6E-8637-DE53003D4848Q36363607-6A3BBF36-F1D3-4F36-8B61-DCD9077BE499Q36429042-E96D4236-FED6-4157-AA59-9A2761E6CE90Q36450075-C508F381-9760-475A-9174-1BF7474DF3A7Q36489313-BE247F46-6F46-4009-BA0D-2D942F208A98
P2860
Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh-hant
name
Micellar complexes of human ap ...... rom cholate-lipid dispersions.
@en
Micellar complexes of human ap ...... rom cholate-lipid dispersions.
@nl
type
label
Micellar complexes of human ap ...... rom cholate-lipid dispersions.
@en
Micellar complexes of human ap ...... rom cholate-lipid dispersions.
@nl
prefLabel
Micellar complexes of human ap ...... rom cholate-lipid dispersions.
@en
Micellar complexes of human ap ...... rom cholate-lipid dispersions.
@nl
P1476
Micellar complexes of human ap ...... from cholate-lipid dispersions
@en
P304
P407
P577
1982-04-01T00:00:00Z